Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives

2 days ago · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty-five ratings firms that are …

CouponFollow Extension

$0.87
OFF

Alnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis

3 weeks from now

3 days ago · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) announced its earnings results on Thursday, October, 31st. The biopharmaceutical company reported ($0.87) EPS for the …

marketbeat.com

$240.51
OFF

Needham & Company LLC Reaffirms “Buy” Rating For Alnylam ...

3 weeks from now

Jan 15, 2025 · Alnylam Pharmaceuticals stock opened at $240.51 on Monday. The company has a debt-to-equity ratio of 31.64, a current ratio of 2.75 and a quick ratio of 2.69. Alnylam …

etfdailynews.com

8%
OFF

Alnylam Pharmaceuticals (ALNY) Is A Great Momentum Stock

3 weeks from now

Oct 23, 2024 · Over the past quarter, shares of Alnylam Pharmaceuticals have risen 26.8%, and are up 80.82% in the last year. In comparison, the S&P 500 has only moved 5.5% and …

nasdaq.com

$0.87
OFF

Research Analysts Offer Predictions For ALNY Q1 Earnings

3 weeks from now

1 day ago · Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) last released its earnings results on Thursday, October 31st.The biopharmaceutical company reported ($0.87) …

etfdailynews.com

28%
OFF

Alnylam Pharmaceuticals Inc Stock - WallStreetZen

3 weeks from now

3 days ago · (NASDAQ: ALNY) Alnylam Pharmaceuticals's 52-week high was $304.39, and its 52-week low was $141.98. It is currently -8.28% from its 52-week high and 96.65% from its 52 …

wallstreetzen.com

$440.24
OFF

Alnylam Pharmaceuticals (ALNY) Earnings Date And Reports 2025

3 weeks from now

4 days ago · Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded net income of -$440.24 million. ALNY has generated -$2.62 earnings per share over the last four quarters. ... Receive …

marketbeat.com

2%
OFF

Here's Why Alnylam Pharmaceuticals (ALNY) Is A Strong …

3 weeks from now

Jan 23, 2025 · Shares of Alnylam Pharmaceuticals has seen some interesting price action recently; the stock is up 6.2% over the past one week and up 9.6% over the past four weeks. …

yahoo.com

9%
OFF

Robeco Institutional Asset Management B.V. Raises Position In …

3 weeks from now

1 day ago · Robeco Institutional Asset Management B.V. boosted its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 35.9% in the 4th quarter, according …

marketbeat.com

94%
OFF

Validea Detailed Fundamental Analysis - ALNY - Nasdaq

3 weeks from now

4 days ago · alnylam pharmaceuticals, inc. ( ALNY ) is a large-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 94% based on the firm’s …

nasdaq.com

FAQs about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Coupon?

Should you buy Alnylam Pharmaceuticals (ALNY) stock?

Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-four brokerages that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and eighteen have issued a buy rating on the company. ...

How much did Alnylam Pharmaceuticals (ALNY) earn?

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings per share of ($2.21) for the quarter, which was $0.49 more than the analysts' consensus estimates of ($1.72). ...

Is Alnylam Pharma a good buy?

Currently, the analyst consensus on Alnylam Pharma is a Moderate Buy with an average price target of $306.32, representing a 13.07% upside. In a report released today, Barclays also assigned a Buy rating to the stock with a $295.00 price target. ...

Who is Alnylam Pharma?

Begin your TipRanks Premium journey today. Alnylam Pharma (ALNY) Company Description: Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. ...

How do I receive news & ratings for Alnylam Pharmaceuticals?

Receive News & Ratings for Alnylam Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter. ...

Does Alnylam Pharmaceuticals have company insights?

ALNY does not have Company Insights Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. ...